Real-World Use of Fingolimod in Patients with Relapsing Remitting Multiple Sclerosis: A Retrospective Study Using the National Multiple Sclerosis Registry in Kuwait

被引：0
作者：
Jasem AL-Hashel
Samar F. Ahmed
Raed Behbehani
Raed Alroughani
机构：
[1] Ibn Sina Hospital,Department of Neurology
[2] Kuwait University,Faculty of Medicine
[3] Minia University,Department of Neurology and Psychiatry
[4] Al-Bahar Eye Center,Department of Ophthalmology
[5] Dasman Diabetes Institute,Neurology Clinic
[6] Amiri Hospital,Division of Neurology, Department of Medicine
来源：
CNS Drugs | 2014年 / 28卷
关键词：
Multiple Sclerosis; Expand Disability Status Scale; Natalizumab; Glatiramer Acetate; Fingolimod;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：817 / 824
页数：7
相关论文
共 50 条
  • [41] Multiple sclerosis in the real world: A systematic review of fingolimod as a case study
    Ziemssen, Tjalf
    Medin, Jennie
    Couto, C. Anne-Marie
    Mitchell, Catherine R.
    AUTOIMMUNITY REVIEWS, 2017, 16 (04) : 355 - 376
  • [42] Effects of fingolimod on focal and diffuse damage in patients with relapsing-remitting multiple sclerosis - The "EVOLUTION" study
    Filippi, Massimo
    Pagani, Elisabetta
    Turrini, Renato
    Bartezaghi, Marta
    Morra, Vincenzo Brescia
    Borriello, Giovanna
    Clerici, Valentina Torri
    Mirabella, Massimiliano
    Pasquali, Livia
    Patti, Francesco
    Totaro, Rocco
    Gallo, Paolo
    Rocca, Maria A.
    JOURNAL OF NEUROLOGY, 2024, : 6181 - 6196
  • [43] The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspective
    Alroughani, Raed
    Van Wijmeersch, Bart
    Al Khaboori, Jabber
    Alsharoqi, Isa Ahmed
    Ahmed, Samar F.
    Hassan, Ali
    Inshasi, Jihad
    Krieger, Derk W.
    Shakra, Mustafa
    Shatila, Ahmed Osman
    Szolics, Miklos
    Khallaf, Mohamed
    Ezzat, Aly
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2020, 13
  • [44] A Retrospective Analysis of Real-World Discontinuation Rates with Delayed-Release Dimethyl Fumarate in Patients with Relapsing–Remitting Multiple Sclerosis
    Michelle Allan
    Lindsay Grant
    Neurology and Therapy, 2020, 9 : 85 - 92
  • [45] Real-world experience of cladribine treatment in relapsing-remitting multiple sclerosis: A Danish nationwide study
    Sorensen, Per Soelberg
    Pontieri, Luigi
    Joensen, Hanna
    Heick, Alex
    Rasmussen, Peter Vestergaard
    Schafer, Jakob
    Ratzer, Rikke
    Pihl, Caroline Ellinore
    Sellebjerg, Finn
    Magyari, Melinda
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 70
  • [46] Short term real-world Fingolimod efficacy and safety in Emirati patients with multiple sclerosis
    Ceccarelli, Antonia
    Mifsud, Victoria
    Abusamra, Eslam
    Hussain, Syed Irteza
    JOURNAL OF CLINICAL NEUROSCIENCE, 2020, 71 : 39 - 42
  • [47] Real-world evidence on the safety and effectiveness of fingolimod in patients with multiple sclerosis from Taiwan
    Yang, Chih-Chao
    Ro, Long-Sun
    Tsai, Nai-Wen
    Lin, Chou-Ching
    Huang, Wen-Nan
    Tsai, Ching-Piao
    Lin, Thy-Sheng
    Su, Jen-Jen
    Huang, Chin-Chang
    Lyu, Rong-Kuo
    Chen, Hsin-Hua
    Lee, Wei-Ju
    Chen, Po-Lin
    Yang, Audrey
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2021, 120 (01) : 542 - 550
  • [48] Fatigue in teriflunomide-treated patients with relapsing remitting multiple sclerosis in the real-world Teri-FAST study
    de Seze, Jerome
    Devy, Richard
    Planque, Evelyne
    Delabrousse-Mayoux, Jean Philippe
    Vandhuick, Olivier
    Kabir, Marmar
    Gherib, Amel
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 47
  • [49] Real-world disability improvement in patients with relapsing-remitting multiple sclerosis treated with natalizumab in the Tysabri Observational Program
    Wiendl, Heinz
    Spelman, Tim
    Butzkueven, Helmut
    Kappos, Ludwig
    Trojan, Maria
    Su, Ray
    Campbell, Nolan
    Ho, Pei-Ran
    Licata, Stephanie
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (05) : 719 - 728
  • [50] Natalizumab use in pediatric patients with relapsing-remitting multiple sclerosis
    Arnal-Garcia, Carmen
    Rosa Garcia-Montero, Ma
    Malaga, Ignacio
    Millan-Pascual, Jorge
    Oliva-Nacarino, Pedro
    Ramio-Torrenta, Lluis
    Oreja-Guevara, Celia
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2013, 17 (01) : 50 - 54
12345